Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Wortmann

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Rheumatic Diseases Clinics of North America|March 30, 2011
Preface: myopathiesRobert L Wortmann
The Journal of Rheumatology|October 3, 2006
The management of gout: it should be crystal clearRobert L Wortmann
Current Rheumatology Reports|May 12, 2004
Treatment of acute gouty arthritis: one physician's approach and where this management stands relative to developments in the fieldRobert L Wortmann
Current Opinion in Rheumatology|April 20, 2005
Recent advances in the management of gout and hyperuricemiaRobert L Wortmann
Arthritis and Rheumatism|October 7, 2005
Academic rheumatology: like it, leave it, or fight to change itRobert L Wortmann
Current Opinion in Rheumatology|May 1, 2002
Gout and hyperuricemiaRobert L Wortmann
Current Opinion in Rheumatology|November 1, 2002
Lipid-lowering agents and myopathyRobert L Wortmann
Cleveland Clinic Journal of Medicine|October 1, 2005
Dose-related statin myopathy: is it an issue?Robert L Wortmann
Rheumatic Diseases Clinics of North America|January 1, 2003
Differentiating idiopathic inflammatory myopathies from metabolic myopathiesRobert L Wortmann, Salvatore DiMauro
Drugs & Aging|January 20, 2007
Management of gout in older adults: barriers to optimal controlKarl T Hoskison, Robert L Wortmann
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Rheumatic Diseases Clinics of North America|March 30, 2011
Preface: myopathiesRobert L Wortmann
The Journal of Rheumatology|October 3, 2006
The management of gout: it should be crystal clearRobert L Wortmann
Current Rheumatology Reports|May 12, 2004
Treatment of acute gouty arthritis: one physician's approach and where this management stands relative to developments in the fieldRobert L Wortmann
Current Opinion in Rheumatology|April 20, 2005
Recent advances in the management of gout and hyperuricemiaRobert L Wortmann
Arthritis and Rheumatism|October 7, 2005
Academic rheumatology: like it, leave it, or fight to change itRobert L Wortmann
Current Opinion in Rheumatology|May 1, 2002
Gout and hyperuricemiaRobert L Wortmann
Current Opinion in Rheumatology|November 1, 2002
Lipid-lowering agents and myopathyRobert L Wortmann
Cleveland Clinic Journal of Medicine|October 1, 2005
Dose-related statin myopathy: is it an issue?Robert L Wortmann
Rheumatic Diseases Clinics of North America|January 1, 2003
Differentiating idiopathic inflammatory myopathies from metabolic myopathiesRobert L Wortmann, Salvatore DiMauro
Drugs & Aging|January 20, 2007
Management of gout in older adults: barriers to optimal controlKarl T Hoskison, Robert L Wortmann
Pageof 4